E. ATAĞ Et Al. , "FOLFOXIRI and Bevacizumab Regimen as a Second-Line Therapy: a Case Report ," 4th International Gastrointestinal Cancer Conference , İstanbul, Turkey, 2014
ATAĞ, E. Et Al. 2014. FOLFOXIRI and Bevacizumab Regimen as a Second-Line Therapy: a Case Report . 4th International Gastrointestinal Cancer Conference , (İstanbul, Turkey).
ATAĞ, E., SEMİZ, H. S., KAZAZ, S. N., DEMİR, N., OFLAZOĞLU, U., ÜNEK, İ. T., ... YAVUZŞEN, T.(2014). FOLFOXIRI and Bevacizumab Regimen as a Second-Line Therapy: a Case Report . 4th International Gastrointestinal Cancer Conference, İstanbul, Turkey
ATAĞ, ELİF Et Al. "FOLFOXIRI and Bevacizumab Regimen as a Second-Line Therapy: a Case Report ," 4th International Gastrointestinal Cancer Conference, İstanbul, Turkey, 2014
ATAĞ, ELİF A. Et Al. "FOLFOXIRI and Bevacizumab Regimen as a Second-Line Therapy: a Case Report ." 4th International Gastrointestinal Cancer Conference , İstanbul, Turkey, 2014
ATAĞ, E. Et Al. (2014) . "FOLFOXIRI and Bevacizumab Regimen as a Second-Line Therapy: a Case Report ." 4th International Gastrointestinal Cancer Conference , İstanbul, Turkey.
@conferencepaper{conferencepaper, author={ELİF ATAĞ AKYÜREK Et Al. }, title={FOLFOXIRI and Bevacizumab Regimen as a Second-Line Therapy: a Case Report }, congress name={4th International Gastrointestinal Cancer Conference}, city={İstanbul}, country={Turkey}, year={2014}}